Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses

Morales-Sánchez A, Fuentes-Pananá EM. Human viruses and cancer. Viruses. 2014;6(10):4047–79.

Article  PubMed  PubMed Central  Google Scholar 

Aga M, Bentz GL, Raffa S, Torrisi MR, Kondo S, Wakisaka N, et al. Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes. Oncogene. 2014;33(37):4613–22.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zur Hausen H, de Villiers E-M, editors. Cancer “causation” by infections—individual contributions and synergistic networks. In: Seminars in oncology. Elsevier; 2014.

Zamaraev A, Zhivotovsky B, Kopeina G. Viral infections: negative regulators of apoptosis and oncogenic factors. Biochem Mosc. 2020;85(10):1191–201.

Article  CAS  Google Scholar 

Krump NA, You J. Molecular mechanisms of viral oncogenesis in humans. Nat Rev Microbiol. 2018;16(11):684–98.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Syn NL, Wang L, Chow EK-H, Lim CT, Goh B-C. Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends Biotechnol. 2017;35(7):665–76.

Article  PubMed  CAS  Google Scholar 

Johnstone R, Bianchini A, Teng K. Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. 1989.

Rahmati S, Shojaei F, Shojaeian A, Rezakhani L, Dehkordi MB. An overview of current knowledge in biological functions and potential theragnostic applications of exosomes. Chem Phys Lipid. 2020;226:104836.

Article  CAS  Google Scholar 

Yáñez-Mó M, Siljander PR-M, Andreu Z, Bedina Zavec A, Borràs FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4(1):27066.

Article  PubMed  Google Scholar 

Yang J, Ding J, Guo X, Zhu X-Q, Zheng Y. Exosomes in virus-associated cancer. Cancer Lett. 2018;438:44–51.

Article  PubMed  Google Scholar 

Donoso-Quezada J, Ayala-Mar S, González-Valdez J. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review. Crit Rev Biotechnol. 2020;40(6):804–20.

Article  PubMed  CAS  Google Scholar 

Nam GH, Choi Y, Kim GB, Kim S, Kim SA, Kim IS. Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy. Adv Mater. 2020;32(51):2002440.

Article  CAS  Google Scholar 

Meckes DG, Shair KH, Marquitz AR, Kung C-P, Edwards RH, Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci. 2010;107(47):20370–5.

Article  PubMed  PubMed Central  Google Scholar 

Zhang L, Ju Y, Chen S, Ren L. Recent progress on exosomes in RNA virus infection. Viruses. 2021;13(2):256.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Anderson MR, Kashanchi F, Jacobson S. Exosomes in viral disease. Neurotherapeutics. 2016;13(3):535–46.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meckes DG Jr. Exosomal communication goes viral. J Virol. 2015;89(10):5200–3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nanbo A, Kawanishi E, Yoshida R, Yoshiyama H. Exosomes derived from Epstein–Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. J Virol. 2013;87(18):10334–47.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Choi H, Lee H, Kim SR, Gho YS, Lee SK. Epstein–Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol. 2013;87(14):8135–44.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci. 2010;107(14):6328–33.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kannan A, Hertweck KL, Philley JV, Wells RB, Dasgupta S. Genetic mutation and exosome signature of human papilloma virus associated oropharyngeal cancer. Sci Rep. 2017;7(1):1–10.

Article  Google Scholar 

Kapoor NR, Chadha R, Kumar S, Choedon T, Reddy VS, Kumar V. The HBx gene of hepatitis B virus can influence hepatic microenvironment via exosomes by transferring its mRNA and protein. Virus Res. 2017;240:166–74.

Article  PubMed  CAS  Google Scholar 

Zhao X, Wu Y, Duan J, Ma Y, Shen Z, Wei L, et al. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC–MS/MS. J Proteome Res. 2014;13(12):5391–402.

Article  PubMed  CAS  Google Scholar 

Yang X, Li H, Sun H, Fan H, Hu Y, Liu M, et al. Hepatitis B virus-encoded microRNA controls viral replication. J Virol. 2017;91(10):e01919-e2016.

Article  PubMed  PubMed Central  Google Scholar 

Mahmoudvand S, Shokri S, Mirzaei H, Makvandi M, Teimoori A, Neisi N, et al. Study on the prevalence of occult hepatitis B virus infection in patients undergoing hemodialysis. Acta Med Iran. 2020;58(4):177–82.

Google Scholar 

Shokri S, Mahmoudvand S, Taherkhani R, Farshadpour F, Jalalian FA. Complexity on modulation of NF-κB pathways by hepatitis B and C: a double-edged sword in hepatocarcinogenesis. J Cell Physiol. 2019;234(9):14734–42.

Article  CAS  Google Scholar 

Lavorgna A, Matsuoka M, Harhaj EW. A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation. Retrovirology. 2015;12(1):1.

Google Scholar 

Yonezawa A, Grant R, Shimakawa Y. Including the voice of people living with viral hepatitis: lessons learned from Japan to accelerate progress towards global hepatitis elimination. Trop Med Health. 2021;49(1):79.

Article  PubMed  PubMed Central  Google Scholar 

D’Souza S, Lau KC, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol. 2020;26(38):5759–83.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Jia X, Chen J, Megger DA, Zhang X, Kozlowski M, Zhang L, et al. Label-free proteomic analysis of exosomes derived from inducible hepatitis B virus-replicating HepAD38 cell line. Mol Cell Proteomics. 2017;16(4):S144–60.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Manandhar S, Kothandan VK, Oh J, Yoo SH, Hwang J, Hwang SR. A pharmaceutical investigation into exosomes. J Pharm Investig. 2018;48(6):617–26.

Article  CAS  Google Scholar 

Lee Y-R, Wu S-Y, Chen R-Y, Lin Y-S, Yeh T-M, Liu H-S. Regulation of autophagy, glucose uptake, and glycolysis under dengue virus infection. Kaohsiung J Med Sci. 2020;36(11):911–9.

Article  PubMed  CAS  Google Scholar 

Wang J, Cao D, Yang J. Exosomes in hepatitis B virus transmission and related immune response. Tohoku J Exp Med. 2020;252(4):309–20.

Article  PubMed  CAS  Google Scholar 

Pezzuto F, Buonaguro L, Buonaguro FM, Tornesello ML. The role of circulating free DNA and microRNA in non-invasive diagnosis of HBV- and HCV-related hepatocellular carcinoma. Int J Mol Sci. 2018;19(4):1007.

Article  PubMed  PubMed Central  Google Scholar 

Yang Y, Han Q, Hou Z, Zhang C, Tian Z, Zhang J. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction. Cell Mol Immunol. 2017;14(5):465–75.

Article  PubMed  CAS  Google Scholar 

Ding J, Wang J, Chen J. Exosomes as therapeutic vehicles in liver diseases. Ann Transl Med. 2021;9(8):735.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sung PS, Jang JW. Natural killer cell dysfunction in hepatocellular carcinoma: pathogenesis and clinical implications. Int J Mol Sci. 2018;19(11):3648.

Article  PubMed  PubMed Central  Google Scholar 

Shi Y, Du L, Lv D, Li Y, Zhang Z, Huang X, et al. Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases. J Gastroenterol. 2021;56(4):336–49.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li JH, Ma WJ, Wang GG, Jiang X, Chen X, Wu L, et al. Clinicopathologic significance and prognostic value of programmed cell death ligand 1 (PD-L1) in patients with hepatocellular carcinoma: a meta-analysis. Front Immunol. 2018;9:2077.

Article 

留言 (0)

沒有登入
gif